Finding studies
Finding studies
RATIONALE: Lapatinib may stop the growth of tumor cells by blocking some of the enzymes needed for cell growth. PURPOSE: This phase I trial is studying the side effects and best dose of lapatinib in treating patients with advanced or metastatic breast cancer that overexpresses HER2.
Take this into the appointment.
Saves the questions and what to expect into your notes, next to the visit they belong to.